We are live on
!
Find out more
CDH
Charles D. Hyman Portfolio holdings
AUM
$1.79B
1-Year Est. Return
17.18%
This Fund
S&P 500
This Quarter
Est. Return
+1.5%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$889M
AUM Growth
+$21.7M
(+2.5%)
Cap. Flow
+$15M
Cap. Flow
% of AUM
1.68%
Top 10 Holdings %
Top 10 Hldgs %
32.12%
Holding
184
New
7
Increased
53
Reduced
66
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GS.PRJ
GOLDMAN SACHS GROUP, INC. 5.50% SER J
GS.PRJ
|
+$1.88M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$1.78M |
| 3 |
Apple
AAPL
|
+$1.64M |
| 4 |
Intuit
INTU
|
+$1.04M |
| 5 |
FedEx
FDX
|
+$941K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$581K |
| 2 |
GE Aerospace
GE
|
+$417K |
| 3 |
Wells Fargo
WFC
|
+$368K |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$254K |
| 5 |
Cummins
CMI
|
+$227K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.67% |
| 2 | Financials | 12.32% |
| 3 | Technology | 9.18% |
| 4 | Consumer Staples | 8.29% |
| 5 | Healthcare | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMX
176
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $17K | ﹤0.01% |
15,143
| – | – |
|
|
177
Cummins
CMI
$91.7B
| – | – |
-1,400
| Closed | -$227K |
|
178
EOG Resources
EOG
$78B
| – | – |
-2,000
| Closed | -$211K |
|
179
Eaton
ETN
$157B
| – | – |
-2,610
| Closed | -$209K |
|
180
Yum China
YUMC
$14.9B
| – | – |
-4,968
| Closed | -$206K |
|
|
EV
181
DELISTED
Eaton Vance Corp.
EV
| – | – |
-3,700
| Closed | -$206K |
|
|
AGN
182
DELISTED
Allergan plc
AGN
| – | – |
-1,262
| Closed | -$212K |
|
|
MON
183
DELISTED
Monsanto Co
MON
| – | – |
-4,975
| Closed | -$581K |
|
|
NVIV
184
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| – | – |
-2
| Closed | -$16K |
|
Similar funds
AT
BPCA
HIG
H
LFDLE
PRIG
PO
GC
Charles D. Hyman's Q2 2018 Portfolio in Review
As of Q2 2018, Charles D. Hyman held 184 positions worth $889M, up 2.5% from $868M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Charles D. Hyman's Q2 2018 filing shows 7 new, 53 increased, 66 reduced and 8 closed positions. Its largest new stake was Intuit: 5,448 shares worth $1.11M. The largest sale was Monsanto Co, an estimated $581K.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
- Charles D. Hyman's largest Q2 2018 buy was Intuit: 5,448 shares worth $1.11M.
- Charles D. Hyman added most to GOLDMAN SACHS GROUP, INC. 5.50% SER J in Q2 2018, an estimated $1.88M increase.
- Charles D. Hyman's biggest Q2 2018 reduction was GE Aerospace, cutting an estimated $417K.
- Charles D. Hyman fully exited Monsanto Co in Q2 2018, selling an estimated $581K.
- Charles D. Hyman's ten largest holdings make up 32% of its $889M portfolio in Q2 2018.
- Charles D. Hyman opened 7 new positions and closed 8 in Q2 2018.
- Charles D. Hyman's portfolio value rose 2.5% quarter-over-quarter to $889M.
Based on Charles D. Hyman's 13F filing for Q2 2018, filed 6 Aug 2018.